D. Thomas Oakley
Directeur des opérations chez Psychogenics, Inc.
Profil
D.
Thomas Oakley is currently the COO & President-Contract Research Organization at Psychogenics, Inc. He previously worked as the President & CEO at Bridge Pharmaceuticals, Inc. and ChanTest Corp.
He also served as the Vice President-Finance at Labcorp Drug Development, Inc. In addition, he was the Chief Operating Officer at Inotiv, Inc. from 2019 to 2020 and the President & COO at MPI Research, Inc. from 2013 to 2014.
Oakley received his undergraduate degree from Ripon College and his MBA from Kellogg School of Management.
Postes actifs de D. Thomas Oakley
| Sociétés | Poste | Début |
|---|---|---|
Psychogenics, Inc.
 Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Directeur des opérations | 28/06/2022 |
Anciens postes connus de D. Thomas Oakley
| Sociétés | Poste | Fin |
|---|---|---|
| INOTIV, INC. | Directeur des opérations | 12/06/2020 |
MPI Research, Inc.
 MPI Research, Inc. Miscellaneous Commercial ServicesCommercial Services MPI Research, Inc. provides preclinical research and development services. It offers drug safety, discovery sciences, bio-analytical and analytical solutions, surgical services, medical device evaluation, and specialty services. The company was founded by William U. Parfet in 1995 and is headquartered in Mattawan, MI. | President | 01/09/2014 |
| COVANCE INC. | Directeur Financier/CFO | - |
ChanTest Corp.
 ChanTest Corp. Miscellaneous Commercial ServicesCommercial Services ChanTest Corp. provided testing and discovery services to pharmaceutical and biotech companies. Its services included safety, discovery, cell biology and transporters. The company was founded by Arthur M. Brown in 1998 and was headquartered in Cleveland, OH. | Directeur Général | - |
Bridge Pharmaceuticals, Inc.
 Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs. | Directeur Général | - |
Formation de D. Thomas Oakley
| Ripon College | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INOTIV, INC. | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Bridge Pharmaceuticals, Inc.
Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs. | Commercial Services |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
ChanTest Corp.
ChanTest Corp. Miscellaneous Commercial ServicesCommercial Services ChanTest Corp. provided testing and discovery services to pharmaceutical and biotech companies. Its services included safety, discovery, cell biology and transporters. The company was founded by Arthur M. Brown in 1998 and was headquartered in Cleveland, OH. | Commercial Services |
MPI Research, Inc.
MPI Research, Inc. Miscellaneous Commercial ServicesCommercial Services MPI Research, Inc. provides preclinical research and development services. It offers drug safety, discovery sciences, bio-analytical and analytical solutions, surgical services, medical device evaluation, and specialty services. The company was founded by William U. Parfet in 1995 and is headquartered in Mattawan, MI. | Commercial Services |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Health Technology |
